Research news

Men with high-risk, locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, following landmark findings from a clinical trial co-led by an oncology consultant at UCLH.

A new scan could improve how millions of people with high blood pressure are treated, suggests a new study led by UCL and conducted at UCLH.

Patients with an aggressive form of leukaemia will now be able to receive a breakthrough immunotherapy on the NHS which was developed and trialled at UCLH and UCL.

The Queen Square Clinical Trial Centre (QSCTC) has successfully delivered its first investigational medicinal product (IMP) treatment on John Young Ward at the National Hospital for Neurology and Neurosurgery.